Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis

Journal of Gastroenterology

Volumn 48, Issue 8, 2013, Pages 910-920

  Zafra, Ma Paz ^a,d   Cancelliere, Natally ^b   Rodríguez Del Río, Pablo ^c   Ruiz García, Mónica ^a   Estévez, Laura ^a   Andregnette, Victoria ^a   Sánchez García, Silvia ^c   Fiandor, Ana ^b   Collantes, Elena ^b   Sastre, Joaquín ^a,d   Quirce, Santiago ^b,d   Ibáñez, María Dolores ^c   Del Pozo, Victoria ^a,d  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Eosinophilic esophagitis; SOCS1; SOCS3

Indexed keywords

CHEMOKINE RECEPTOR CCR3; EOTAXIN 3; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 5; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR MECHANICS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; CYTOKINES; EOSINOPHILIC ESOPHAGITIS; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH2 CELLS; YOUNG ADULT;

EID: 84884354880     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0723-8     Document Type: Article

References (38)

1. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-63.
2. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940-1.
3. Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115:418-9.
4. Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology. 2009;137:1238-49.
5. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20.
6. Blanchard C, Rothenberg ME. Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:133-43.
7. Gupta SK, Fitzgerald JF, Kondratyuk T, HogenEsch H. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:22-6.
8. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopatic eosinophilic esophagitis is associated with a t(h)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954-61.
9. Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol. 2004;22:503-29.
10. Barrett NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity. 2009;1:425-37.
11. Palmer DC, Restifo NP. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol. 2009;30:592-602.
12. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol. 2003;4:1169-76.
13. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol. 2008;19:414-22.
14. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Gerra FM, Rottapel RL. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev. 2008;224:265-83.
15. Cassel SL, Rothman PB. Chapter 3: role of SOCS in allergic and innate immune responses. Adv Immunol. 2009;103:49-76.
16. Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol. 2011;31:980-5.
17. Yoshimura Y, Naka T, Kubo M. SOCS proteins, cytokine signaling and immune regulation. Nat Immunol. 2007;7:454-65.
18. EAACI Subcommittee of Skin Test and Allergen Standardization. Skin tests used in type I allergy testing. Allergy. 1989;44(s10):13-60.
19. Niemeijer NR, Goedewaagen B, Kauffman HF, de Monchy JG. Optimization of skin testing. I. Choosing allergen concentrations and cut off values by factorial design. Allergy. 1993;48(7):491-7.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods. 2001;25:402-8.
21. Bradford MM. A rapid and sensitive method for quantitation of micrograms quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
22. Liacouras CA, Spergel JM, Ruchelli E, Ruchelli E, Verma R, Mascarenhas M, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198-206.
23. Baxi S, Gupta SK, Swigonski N, Swingonski N, Fitzgerald JF. Clinical presentation of patients with eosinophilic inflammation of the esophagus. Gastrointest Endosc. 2006;64:473-8.
24. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48:30-6.
25. López E, Zafra MP, Sastre B, Gámez C, Fernández- Nieto M, Sastre J, et al. Suppressors of cytokine signaling 3 (SOCS3) expression in eosinophils: regulation by PGE2 and Th2 cytokines. Clin Dev Immunol. 2011;2011:917015.
26. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120:1292-300.
27. Sands WA, Woolson HD, Milne GR, Rutherford C, Palmer TM. Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol Cell Biol. 2006;26:6333-46.
28. Borland G, Bird RJ, Palmer TM, Yarwood SJ. Activation of protein kinase Calpha by EPAC1 is required for the ERK- and CCAAT/enhancer-binding protein beta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cells. J Biol Chem. 2009;284:17391-403.
29. Dellon ES, Bower JJ, Keku TO, Chen X, Miller CR, Woosley JT, et al. Markers of tyrosine kinase activity in eosinophilic esophagitis: a pilot study of the FIP1L1-PDGFRα fusion gene, pERK 1/2, and pSTAT5. Dis Esophagus. 2012;25(2):166-74.
30. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol. 2003;111:227-42.
31. Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev. 2011;242(1):161-77.
32. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536-47.
33. Brown-Whitehorn TF, Spergel JM. The link between allergies and eosinophilic esophagitis: implications for management strategies. Expert Rev Clin Immunol. 2010;6:101-9.
34. Mishra A, Hogan SP, Brandt EB, Rothenberg ME, et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168:2464-9.
35. Mishra A, Wang M, Pemmaraju VR, Collins MH, Fulkerson PC, Abonia JP, et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134:204-14.
36. Blanchard C, Stucke EM, Rodriguez-Jimenez B, Burwinkel K, Collins MH, Ahrens A, et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 2011;127:208-17.
37. Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C, et al. Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J. 2002;16:598-600.
38. Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA, et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood. 2000;95:1911-7.